Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 1
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.
Akiyama S, Yokoyama K, Yagi S, Shinzaki S, Tsuruta K, Yoshioka S, Sako M, Shimizu H, Kobayashi M, Sakurai T, Nomura K, Shibuya T, Takahara M, Hiraoka S, Sugai K, Yanai S, Yoshida A, Koroku M, Omori T, Saruta M, Matsumoto T, Okamoto R, Tsuchiya K, Fujii T. Akiyama S, et al. Among authors: yagi s. Aliment Pharmacol Ther. 2024 Jun;59(11):1413-1424. doi: 10.1111/apt.17961. Epub 2024 Mar 17. Aliment Pharmacol Ther. 2024. PMID: 38494867
Ischemic enteritis resulting from polycythemia vera.
Yagi S, Kioka K, Koizumi Y, Nakai T, Kawasaki Y, Tsutsumi M, Ishii N, Yamasaki T, Nebiki H, Maeda K. Yagi S, et al. Clin J Gastroenterol. 2022 Oct;15(5):907-912. doi: 10.1007/s12328-022-01673-x. Epub 2022 Jul 13. Clin J Gastroenterol. 2022. PMID: 35831680
Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody.
Ikenouchi M, Fukui H, Yagi S, Nogami A, Kaku K, Sato T, Kawai M, Kamikozuru K, Yokoyama Y, Takagawa T, Tomita T, Kobayashi T, Shinzaki S. Ikenouchi M, et al. Among authors: yagi s. Intest Res. 2025 Feb 3. doi: 10.5217/ir.2024.00148. Online ahead of print. Intest Res. 2025. PMID: 39894450 Free article.
Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
Sato T, Uchino M, Takeuchi J, Fujihira Y, Shimizu K, Yokoyama K, Yagi S, Kaku K, Takashima Y, Ikenouchi M, Kojima K, Kawai M, Nagase K, Kamikozuru K, Yokoyama Y, Takagawa T, Ikeuchi H, Watanabe K, Shinzaki S. Sato T, et al. Among authors: yagi s. Clin Nutr. 2023 May;42(5):722-731. doi: 10.1016/j.clnu.2023.03.012. Epub 2023 Mar 18. Clin Nutr. 2023. PMID: 37001195
Real-World Effectiveness and Safety of Mirikizumab Induction Therapy in Patients With Ulcerative Colitis: A Multicentre Retrospective Observational Study.
Takagi Y, Sato T, Nishiguchi T, Nogami A, Igeta M, Yagi S, Ikenouchi M, Kawai M, Kamikozuru K, Yokoyama Y, Tomita T, Fukui H, Fukata M, Kobayashi T, Shinzaki S. Takagi Y, et al. Among authors: yagi s. Aliment Pharmacol Ther. 2025 Apr 9. doi: 10.1111/apt.70140. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 40205711